The National Security Commission on Emerging Biotechnology is visiting Pittsburgh to explore how biotechnology and artificial ...
If confirmed by the US Senate, Jim O'Neill would be the first non-scientist or engineer to lead the agency, a big funder of ...
The Brighterside of News on MSN
AI breakthrough could dramatically lower the cost of drug development
Three-letter DNA “words” can decide whether a yeast cell cranks out a medicine efficiently or sputters along. The words are ...
First patient successfully enrolled in global registrational study in Australia - Operational presence in Australia positions Serina to advance enrollment in Cohort 1 - Company remains on track for ...
IITs now offer various programs that do not require JEE scores, such as executive robotics (IIT Delhi), genetic engineering (IIT Guwahati), engineering mathematics (IIT Kharagpur), thermodynamics (IIT ...
First patient successfully enrolled in global registrational study in Australia - Operational presence in Australia positions Serina to advance enrollment in Cohort 1- Company remains on track for ...
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its ...
Research and Development (R&D) expenses: R&D expenses totaled $44.6 million for the fourth quarter of 2025 and $50.5 million ...
Bioxytran inks commercial distribution agreement with Khoury Medical for A-SUQAR dietary supplement: Boston, Massachusetts Thursday, February 19, 2026, 14:00 Hrs [IST] Bioxytran, ...
SONRISA, a new science-led Korean skincare brand created for Indian skin and climate, officially enters the Indian beauty landscape with a clear point of view: skincare should be intentional, ...
Study expected to enroll 24 patients with the option to enroll an additional 45 patients at the recommended Phase 2 doseProtocol calls for three doses of STAR-LLD administered by continuous ...
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results